MediTox

… You develop the ideas, we can help you navigate through challenges of preclinical research

Our focus

MediTox is a GLP-certified CRO with more than 25 years’ experience in preclinical toxicology and extensive experience with variety of compounds and therapeutic areas, capable to conduct studies in full compliance with GLP standards and other international guidelines (EMA/ICH, VICH, OECD, FDA, ISO10993), providing core range of nonclinical studies enabling IND/registration for human drugs, biologicals and safety (TAS/BEQ/efficacy) studies for registration of veterinary drugs.
One of the few facilities in Europe using cats as target animals for the testing of veterinary drugs.

Whether you are just starting out or dealing with a specific issue, we are ready to discuss everything with you and propose a set of studies.
Quality
Compliance with OECD TG, EMA/ICH, VICH, ISO 10993
Human health
Compliance with OECD TG, EMA/ICH, EFSA, ISO 10993
Animal health
Compliance with VICH, EFSA
Medical device
Compliance with OECD TG, ISO 10993

Mission & vision

We are dedicated to being a reliable partner for our clients in bringing innovative ideas to market, with unwavering adherence to scientific integrity and business ethics.

Our goal is to be recognized as a trusted and respected partner in the field of drug development — known for our strong team of top-tier experts, high professional standards, flexibility, and a personalized, friendly approach to every client.

We strive for excellence in both operations and service by expertise. Through close collaboration with the scientific community, we ensure the highest quality of our services and continually work to enhance client satisfaction.

Key Highlights

  • Extensive expertise in non-rodent toxicology
  • Validated models for human diseases, including influenza, chronic glaucoma, osteoarthritis
  • One of the few facilities in Europe offering TAS and bioequivalence studies in cats
  • Dedicated team of experts specialized in advanced veterinary surgical procedures
  • Trusted research partner in multiple awarded European grant projects

Our team

Board of Directors

Expert Team

Business Development

News & Events

EU Support for MediTox’s International Expansion

MediTox s.r.o. received support from the program Marketing – Challenge I – participation in foreign events, co-funded by the European Union. This funding helped strengthen the company’s international presence and supported its participation in key industry events abroad.

Life Science Baltics 2025

MediTox s.r.o. proudly participated in Life Sciences Baltics 2025, the leading event in the Baltic region dedicated to biotechnology, pharmaceutical, and medical innovation. The event provided an excellent opportunity for networking, sharing expertise, and exploring new partnerships in the life sciences sector.

MediTox´s authorization was extended

The Ministry of Agriculture of the Czech Republic has again granted MediTox s.r.o. a license to breed and use experimental animals according to par. 15b, par. 20 par. 1 letter g of the Animal Protection Act, valid until 2030, when another regular audit and negotiations on the extension of the license will take place.

Address

MediTox s.r.o.,
Pod Zámkem 279,
281 25 Konárovice, Czech Republic

company ID

25926713

vat number

CZ25926713
Would you like to ask a question? Contact us:
By submitting the form, you agree to the processing of your personal data.

Curriculum vitae

Načítám životopis…